QHow much time does it take and how much does it cost to successfully develop a hybrid with one or more transgenic traits from conception to commercial release. Can you categorize the portion of costs that are incurred as a result of meeting regulatory ap

How much time does it take and how much does it cost to successfully develop a hybrid with one or more transgenic traits from conception to commercial release. Can you categorize the portion of costs that are incurred as a result of meeting regulatory approvals and those that would be incurred even if there were no regulatory approvals required. My understanding is that it takes several years and tens of millions of dollars to obtain regulatory approvals thus effectively excluding public sector and universities, trade associations and other groups from developing and offering traits in the public domain.

AExpert Answer

You are correct that it requires a tremendous investment of both time and resources to bring a new biotech crop to market. A survey completed in 2011 found the cost of discovery, development and authorization of a new plant biotechnology trait introduced between 2008 and 2012 was $136 million. On average, about 26 percent of those costs ($35.1 million) were incurred as part of the regulatory testing and registration process. The same study found that the average time from initiation of a discovery project to commercial launch is about 13 years. The longest phase of product development is regulatory science and registration activities, at about 5.5 years for traits introduced in 2011.

 

While that price tag is significant, so are the losses from pests, diseases and other issues that these new traits are designed to help farmers combat. For example, the U.S. Department of Agriculture has estimated corn rootworm causes $1 billion dollars in damage to the U.S. corn crop alone each year. By delivering traits that can fight these pests, it increases farmers’ productivity.

 

The high costs of commercializing new plant biotechnology can be a challenge to the public sector, universities and others parties. That is where public-private partnerships are essential. DuPont and DuPont Pioneer have a long tradition of taking a collaborative approach to problem-solving. There are numerous examples of organizations working together to further the development of a promising trait or technology, including DuPont-supported initiatives such as the African Biofortified Sorghum and Improved Maize for African Soils projects.

Posted on July 30, 2018
Genetic engineering (GE) touches on the routine life of billions of people (but not everyone). Food, clothes, and medicine are commonly made with the help of genetically engineered organisms. Certain medicines, like insulin, could only be mass-produced this way. Fiber for clothes is made less expensive thanks to GE cotton plants. You also PROBABLY sometimes eat plants with a few engineered genes, depending on where you live. But genetic engineering isn’t just for making new or better... Read More
Answer:
Posted on February 28, 2018
This is an important question! Of course scientists wouldn't want to release any plants or products that would be harmful to humans. The first part of the answer is that I'm not aware of ANY examples of released GMOs hurting human bodies. In fact, GMO (or genetically engineered, GE) crops have actually helped both plants and human health, by making harvests more efficient and reducing the need to spray harmful pesticides. Safety to humans is an important part of the... Read More
Answer:
Posted on May 30, 2018
I think the answer for this question is – it depends…. In the developed world where we have access to a wide variety of foods, I think that eating a food derived from a genetically engineered crop it unlikely to expand one’s life expectancy in and of itself.  However, certain components of those crops can certainly contribute to improved health. High oleic soybeans produce a monounsaturated fat that is trans-fat free. Trans-fats can contribute to an increased LDL... Read More